.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Argus Health
Merck
Moodys
McKesson
Healthtrust
Deloitte
UBS
AstraZeneca
Harvard Business School

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,459,163

« Back to Dashboard

Summary for Patent: 5,459,163

Title: Medicament to combat autoimmune diseases
Abstract:A pharmaceutical composition for use in the treatment of chronic Graft-versus-host diseases as well as autoimmune diseases, in particular for the treatment of systemic lupus erythematosus containing as an active ingredient at least one compound of the formulae 1 or 2 ##STR1## the latter being present per se or in the form of a physiologically tolerable salt. The invention also relates to a dosage unit form of said pharmaceutical composition and a method of treating chronic Graft-versus host diseases as well as autoimmune diseases, in particular systemic lupus erythematosus.
Inventor(s): Bartlett; Robert R. (Darmstadt, DE), Schleyerbach; Rudolph (Hofheim am Taunus, DE), Kammerer; Friedrich-Johannes (Hochheim am Main, DE)
Assignee: Hoechst Aktiengesellschaft (Frankfurt, DE)
Application Number:08/119,840
Patent Claim Types:
see list of patent claims
Composition; Compound;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,459,163

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany35 34 440.7Sep 27, 1985

International Patent Family for Patent: 5,459,163

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria96669► Subscribe
Austria122033► Subscribe
Australia588629► Subscribe
Australia6316786► Subscribe
Canada1275251► Subscribe
Cyprus2033► Subscribe
Germany3534440► Subscribe
Germany3650315► Subscribe
Germany3689252► Subscribe
European Patent Office0217206► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Moodys
Johnson and Johnson
Chinese Patent Office
McKinsey
Baxter
Accenture
Argus Health
Express Scripts
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot